PLABiologics is a South Korean gene and cell therapy company founded in 2022 as a CHA University spinout, based in Seongnam. It develops placenta-derived mesenchymal stem cell therapies, led by UNIPla and the non-viral, functionally enhanced SUNIPla, alongside pipelines built on placenta-derived materials, exosomes and natural-product factors. Its goal is placenta-based medicines for degenerative and intractable diseases, backed by two decades of placenta research at CHA University.
1
Round
1
Industry
4
Tags
Sep 21, 2026
Latest raise
Funding activity · 1 round
Sep 21, 2026
KRW -1
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
